DK106146C - Fremgangsmåde til fremstilling af aminoquinolinderivater eller syreadditionssalte deraf. - Google Patents

Fremgangsmåde til fremstilling af aminoquinolinderivater eller syreadditionssalte deraf.

Info

Publication number
DK106146C
DK106146C DK558762AA DK558762A DK106146C DK 106146 C DK106146 C DK 106146C DK 558762A A DK558762A A DK 558762AA DK 558762 A DK558762 A DK 558762A DK 106146 C DK106146 C DK 106146C
Authority
DK
Denmark
Prior art keywords
preparation
acid addition
addition salts
aminoquinoline derivatives
aminoquinoline
Prior art date
Application number
DK558762AA
Other languages
English (en)
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Application granted granted Critical
Publication of DK106146C publication Critical patent/DK106146C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
DK558762AA 1961-12-29 1962-12-21 Fremgangsmåde til fremstilling af aminoquinolinderivater eller syreadditionssalte deraf. DK106146C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR883457 1961-12-29
FR891650 1962-03-20

Publications (1)

Publication Number Publication Date
DK106146C true DK106146C (da) 1966-12-27

Family

ID=26193748

Family Applications (2)

Application Number Title Priority Date Filing Date
DK110364AA DK106147C (da) 1961-12-29 1961-12-21 Fremgangsmåde til fremstilling af aminoquinolinforbindelser eller syreadditionssalte deraf.
DK558762AA DK106146C (da) 1961-12-29 1962-12-21 Fremgangsmåde til fremstilling af aminoquinolinderivater eller syreadditionssalte deraf.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK110364AA DK106147C (da) 1961-12-29 1961-12-21 Fremgangsmåde til fremstilling af aminoquinolinforbindelser eller syreadditionssalte deraf.

Country Status (11)

Country Link
US (1) US3196155A (da)
AT (1) AT242141B (da)
BE (1) BE626239A (da)
CH (1) CH453360A (da)
DE (2) DE1156803B (da)
DK (2) DK106147C (da)
ES (1) ES280829A1 (da)
FR (3) FR42M (da)
GB (1) GB986350A (da)
LU (1) LU41571A1 (da)
NL (1) NL106667C (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515947A (en) * 1982-08-11 1985-05-07 Eastman Kodak Company Cyanoalkylpiperazines and methods for their preparation and use
US5182387A (en) * 1991-10-30 1993-01-26 Merrell Dow Pharmaceuticals Inc. Bis-dibenzoazepine compounds
EP2030967A1 (de) * 2007-08-31 2009-03-04 Sika Technology AG Hydroxylgruppen aufweisende Aldimine und Aldimin enthaltende Zusammensetzungen
EP3971178A1 (en) * 2012-03-07 2022-03-23 The McLean Hospital Corporation Aminoquinoline derivatives and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1012751A (fr) * 1949-01-24 1952-07-17 Rhone Poulenc Sa Nouveau dérivé de la pipérazine et de la quinoléïne et son procédé de préparation
US2901484A (en) * 1957-03-04 1959-08-25 Abbott Lab Bis-quinoliniums
US3020283A (en) * 1958-10-20 1962-02-06 Abbott Lab Bis-lepidines

Also Published As

Publication number Publication date
FR82307A (da) 1900-01-01
DE1156803B (de) 1963-11-07
DE1196202B (de) 1965-07-08
BE626239A (da) 1900-01-01
CH453360A (fr) 1968-06-14
FR42M (da) 1960-11-28
NL106667C (da) 1900-01-01
LU41571A1 (da) 1962-06-19
AT242141B (de) 1965-08-25
ES280829A1 (es) 1963-01-16
DK106147C (da) 1966-12-27
FR82308A (da) 1900-01-01
US3196155A (en) 1965-07-20
GB986350A (en) 1965-03-17

Similar Documents

Publication Publication Date Title
DK109784C (da) Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf.
DK104460C (da) Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf.
DK105205C (da) Fremgangsmåde til fremstilling af pyridyl- eller pyrazyloxyalkylaminoalkylaminer eller syreadditionssalte heraf.
DK106146C (da) Fremgangsmåde til fremstilling af aminoquinolinderivater eller syreadditionssalte deraf.
DK107807C (da) Fremgangsmåde til fremstilling af quinolinderivater eller syreadditionssalte deraf.
DK103672C (da) Fremgangsmåde til fremstilling af phenylpropanolaminer eller syreadditionssalte heraf.
DK108152C (da) Fremgangsmåde til fremstilling af piperidylidenthioxanthenderivater eller syreadditionssalte deraf.
DK104513C (da) Fremgangsmåde til fremstilling af tetraethoxybenzal-tetrahydro-isoquinolinderivater eller syreadditionssalte deraf.
DK102807C (da) Fremgangsmåde til fremstilling af substituerede diphenylalkenylaminer eller syreadditionssalte heraf.
DK110091C (da) Fremgangsmåde til fremstilling af substituerede diphenylalkylaminer eller syreadditionssalte heraf.
DK118189B (da) Analogifremgangsmåde til fremstilling af benzyloxyaminer eller syreadditionssalte heraf.
DK129714B (da) Fremgangsmåde til fremstilling af benzimidazolinoner eller syreadditionssalte deraf.
DK105341C (da) Fremgangsmåde til fremstilling af quinolinderivater eller syreadditionssalte deraf.
DK106041C (da) Fremgangsmåde til fremstilling af 1-phenyl-2-alkylaminoalkanolderivater eller syreadditionssalte deraf.
DK103077C (da) Fremgangsmåde til fremstilling af 4-hydroxyphenyl-4-carbalkoxy-piperidinderivater eller syreadditionssalte deraf.
DK104171C (da) Fremgangsmåde til fremstilling af morfantridinderivater eller syreadditionssalte heraf.
DK102681C (da) Fremgangsmåde til fremstilling af 1-fenyl-2-aminoætanolderivater eller syreadditionssalte heraf.
DK102632C (da) Fremgangsmåde til fremstilling af 1-fenyl-2-aminoætanolderivater eller syreadditionssalte deraf.
DK102682C (da) Fremgangsmåde til fremstilling af 1-fenyl-2-aminoætanolderivater eller syreadditionssalte deraf.
DK102471C (da) Fremgangsmåde til fremstilling af 1-fenyl-2-aminoætanolderivater eller syreadditionssalte deraf.
DK104988C (da) Fremgangsmåde til fremstilling af thenylguanidiner eller syreadditionssalte heraf.
DK101066C (da) Fremgangsmåde til fremstilling af dihalogenaminobenzylaminer eller syreadditionssalte heraf.
DK102517C (da) Fremgangsmåde til fremstilling af dihydrodibenzocyclohetener eller syreadditionssalte heraf.
DK102575C (da) Fremgangsmåde til fremstilling af N-benzodioxylurethaner eller syreadditionssalte heraf.
DK101795C (da) Fremgangsmåde til fermstilling af dihalogenaminobenzylaminer eller syreadditionssalte heraf.